source
- Roche to acquire PathAI for $750 million to boost AI pathologyRoche announced it will acquire Boston based PathAI for an upfront payment of $750 million. The acquisition follows a partnership that began in 2021 and is intended to speed the use of artificial i…
- Former FDA officials and pharma groups weigh in as Supreme Court considers mifepristone regulationThe Supreme Court is expected to act on a case involving the abortion pill mifepristone after a pause on a federal appeals court order that halted mail‑order distribution. The decision could resha…